Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rey, J.
Right arrow Articles by Durand, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rey, J.
Right arrow Articles by Durand, J.-M.
Related Collections
Right arrow Vasculitis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 601-602
© 2003 British Society for Rheumatology

Letters to the Editor

Serotonin reuptake inhibitors, Raynaud's phenomenon and erythromelalgia

J. Rey, E. Cretel, R. Jean, M.-J. Pastor1 and J.-M. Durand

Service de Médecine Interne, Hôpital de la Conception and
1 Service de Pharmacovigilance, Hôpital St Marguerite, Marseilles, France

The first 10% of the full text of this article appears below.

SIR, We read with great interest the report by Coleiro et al. [1] describing a pilot study on the tolerability and efficiency of fluoxetine for the treatment of Raynaud's phenomenon. This study confirmed previous case reports suggesting the usefulness of selective serotonin reuptake inhibitors (SSRIs) in the management of Raynaud's phenomenon [2, 3]. Here . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
M. Colakoglu, V. Cobankara, and T. Akpolat
Effect of Clonazepam on Raynaud's Phenomenon and Fingertip Ulcers in Scleroderma
Ann. Pharmacother., September 1, 2007; 41(9): 1544 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
M. D. P. Davis, F. Wilkins, and T. W. Rooke
Between episodes of erythromelalgia: a spectrum of colors.
Arch Dermatol, August 1, 2006; 142(8): 1085 - 1086.
[Full Text] [PDF]